Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04093921
Other study ID # P00033150
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date June 15, 2020
Est. completion date December 2023

Study information

Verified date October 2023
Source Boston Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized, motivational-interviewing-based intervention to improve readiness-to-change, or willingness to engage in a self-management approach to chronic pain, for patients referred to our intensive interdisciplinary pain rehabilitation day program.


Description:

Readiness to change, or willingness to engage in a self-management approach to chronic pain and disability, is the most powerful predictor of children's success in intensive pediatric pain rehabilitation. Motivational Enhancement Therapy (MET) is an approach that has been effective in increasing readiness to change and treatment engagement for other behaviorally-oriented health interventions. However, MET has never been systemically employed in the context of treating pediatric chronic pain and disability. This demonstration project seeks to test the effects of a novel telehealth intervention using motivation enhancement therapy to improve patient and parent engagement in, and outcomes of, an intensive interdisciplinary day hospital program for children with complex chronic pain conditions and associated disability, the Pediatric Pain Rehabilitation Center (PPRC). The intervention, PPRC-Prep, is a 4 week MET-based telehealth intervention that will be offered to families of children with refractory chronic pain conditions awaiting admission to the PPRC at Boston Children's Hospital at Waltham. Families approved for and awaiting PPRC admission will be randomized to receive PPRC-Prep along with usual care or to a comparison group receiving treatment as usual. Study aims include assessing the feasibility and acceptability of the intervention along with measuring its potential to increase readiness to engage in a self-management approach assessed at time of admission to the PPRC using established measures of readiness to change, pain acceptance, and committed action. Investigators will also evaluate the effects of PPRC-Prep on program length of stay and on reductions of disability and pain at PPRC discharge and short-term (8-week) follow up through comparison of families who undergo PPRC-prep with families who do not undergo PPRC-prep. Demonstrating the feasibility and preliminary effectiveness of PPRC-Prep will enable the study team to establish this as a routine component of our approach to care for children with complex, refractory chronic pain and disability.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 80
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria: - Patient age 8-18 at enrollment - Presence of chronic pain condition for > 3 months with moderate or severe disability - Accepts referral to PPRC and awaiting admission Exclusion Criteria: - Non-English speaking - No access to device with telehealth capability

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
MET-based therapy
see previous
Standard Care
To include all recommended outpatient treatments

Locations

Country Name City State
United States Boston Children's Hospital Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Boston Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Length of stay length of stay in PPRC program (in days) PPRC discharge [within 6 months of baseline]
Primary Functional disability inventory (FDI) total score level of pain related functional disability, ranges from 0-60 with higher scores indicating more disability at PPRC discharge [within 6 months of baseline]
Primary Functional disability inventory (FDI) total score level of pain related functional disability, ranges from 0-60 with higher scores indicating more disability at PPRC follow up (4-8 weeks post discharge)
Primary Functional disability inventory (FDI) total score level of pain related functional disability, ranges from 0-60 with higher scores indicating more disability at PPRC follow up (1 year post discharge)
Primary Pain stages of change questionnaire for adolescents (PSOCQ-A) readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change. PPRC admission (within 2 months of baseline)
Primary Pain stages of change questionnaire for adolescents (PSOCQ-A) readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change. PPRC discharge [within 6 months of baseline]
Primary Pain stages of change questionnaire for adolescents (PSOCQ-A) readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change. at PPRC follow up (4-8 weeks post discharge)
Primary Pain stages of change questionnaire for adolescents (PSOCQ-A) readiness to change/embrace pain self-management. 13 item scale with total scores ranging from 13-65. Domain with highest score is considered current stage of change. at PPRC follow up (1 year post discharge)
Primary Modified Adolescent Treatment Engagement Questionnaire Level of engagement in treatment. Scores 0-40 higher scores indicate more engagement. At end of intervention, 4 weeks from baseline
Primary Treatment satisfaction inventory Participant satisfaction with treatment. 13 items range 13-65, higher scores = more satisfaction At end of intervention, 4 weeks from baseline
Secondary Pain intensity pain intensity on 0-10 numeric scale (10=worst pain) At PPRC admission (4-6 weeks post baseline)
Secondary Pain intensity pain intensity on 0-10 numeric scale (10=worst pain) At PPRC discharge [within 6 months of baseline]
Secondary Pain intensity pain intensity on 0-10 numeric scale (10=worst pain) At first post-treatment follow up (4-8 weeks post discharge)
Secondary Pain intensity pain intensity on 0-10 numeric scale (10=worst pain) 1 year post-treatment
Secondary Chronic Pain Acceptance Questionnaire total score Secondary measure of readiness to change/engage in pain self-management. 20 item questionnaire, will use total score. Range 0-120. HIgher scores indicate more pain acceptance. At PPRC admission [typically within 3 months of baseline]
Secondary Chronic Pain Acceptance Questionnaire total score Secondary measure of readiness to change/engage in pain self-management. 20 item questionnaire, will use total score. Range 0-120. HIgher scores indicate more pain acceptance. At PPRC discharge [within 6 months of baseline]
Secondary Committed action questionnaire total score Secondary measure of readiness to change/engage in pain self-management. 8 item questionnaire with range 0-48. Higher scores indicate more committed action. At PPRC admission [typically within 3 months of baseline]
Secondary Committed action questionnaire Secondary measure of readiness to change/engage in pain self-management. 8 item questionnaire with range 0-48. Higher scores indicate more committed action/readiness. At PPRC discharge [within 6 months of baseline]
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain